Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Gruber

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
AIDS (London, England)|March 7, 2025
Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruptionGraeme Moyle, Joshua Gruber, Megan Dunbar, et al.
The Oncologist|February 6, 2026
Tumor suppressor genes, treatments, and survival in US veterans with prostate cancerKrishny Karunanandaa, Eric Marshall Knoche, Robert Bruce Montgomery, et al.
AIDS (London, England)|September 19, 2025
Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis BDouglas T Dieterich, Laurence Brunet, Ricky K Hsu, et al.
Journal of Clinical and Translational Science|July 15, 2022
Using gamification to enhance clinical trial start-up activitiesKaren Lane, Ryan Majkowski, Joshua Gruber, et al.
Research Square|January 16, 2026
GLP-1 Targeting Agents Impair Chemoimmunotherapy Effectiveness in Triple-Negative Breast CancerJoshua Gruber, Bethania Soares Dos Santos, Maycon Marção, et al.
Clinical Pediatrics|July 27, 2022
A Case-Control Study Evaluating Risk Factors and Outcomes of Hospitalized Children With ESBL-UTISophia Hassor, Veronica Etinger, Diana Sofia Villacis, et al.
Stroke|January 20, 2021
Diffusion-Weighted Imaging Lesions After Intracerebral Hemorrhage and Risk of Stroke: A MISTIE III and ATACH-2 AnalysisSantosh B Murthy, Cenai Zhang, Ajay Gupta, et al.
Human Genetics|January 6, 2017
Association of AHSG with alopecia and mental retardation (APMR) syndromeM Reza Sailani, Fereshteh Jahanbani, Jafar Nasiri, et al.
Cancer Reports (Hoboken, N.J.)|August 28, 2025
Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast CancerSeema Nagpal, Kim-Son Nguyen, Sophie Bertrand, et al.
The Science of the Total Environment|November 26, 2021
Infrastructure alone cannot ensure resilience to weather events in drinking water suppliesKatrina J Charles, Guy Howard, Elena Villalobos Prats, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
AIDS (London, England)|March 7, 2025
Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruptionGraeme Moyle, Joshua Gruber, Megan Dunbar, et al.
The Oncologist|February 6, 2026
Tumor suppressor genes, treatments, and survival in US veterans with prostate cancerKrishny Karunanandaa, Eric Marshall Knoche, Robert Bruce Montgomery, et al.
AIDS (London, England)|September 19, 2025
Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis BDouglas T Dieterich, Laurence Brunet, Ricky K Hsu, et al.
Journal of Clinical and Translational Science|July 15, 2022
Using gamification to enhance clinical trial start-up activitiesKaren Lane, Ryan Majkowski, Joshua Gruber, et al.
Research Square|January 16, 2026
GLP-1 Targeting Agents Impair Chemoimmunotherapy Effectiveness in Triple-Negative Breast CancerJoshua Gruber, Bethania Soares Dos Santos, Maycon Marção, et al.
Clinical Pediatrics|July 27, 2022
A Case-Control Study Evaluating Risk Factors and Outcomes of Hospitalized Children With ESBL-UTISophia Hassor, Veronica Etinger, Diana Sofia Villacis, et al.
Stroke|January 20, 2021
Diffusion-Weighted Imaging Lesions After Intracerebral Hemorrhage and Risk of Stroke: A MISTIE III and ATACH-2 AnalysisSantosh B Murthy, Cenai Zhang, Ajay Gupta, et al.
Human Genetics|January 6, 2017
Association of AHSG with alopecia and mental retardation (APMR) syndromeM Reza Sailani, Fereshteh Jahanbani, Jafar Nasiri, et al.
Cancer Reports (Hoboken, N.J.)|August 28, 2025
Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast CancerSeema Nagpal, Kim-Son Nguyen, Sophie Bertrand, et al.
The Science of the Total Environment|November 26, 2021
Infrastructure alone cannot ensure resilience to weather events in drinking water suppliesKatrina J Charles, Guy Howard, Elena Villalobos Prats, et al.
Pageof 4